Tokyo, Nov. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059900) titled 'Microsatellite Instability (MSI) Screening Study for Resectable Solid Tumors (Excluding Colorectal Cancer)' on Nov. 27.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Malignant solid tumors
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To clarify the frequency of high-frequency microsatellite instability (MSI-H) in resectable solid tumors (excluding colorectal cancer) and the patient background according to MSI status.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old...